{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:45:40Z","timestamp":1790477140058,"version":"4.1.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>To produce a murine monoclonal antibody (mAb) that binds to glycoprotein IIb\/IIIa (\u03b1IIb\u03b23) and inhibits clot retraction (CR), we immunized mice with human platelets and tested hybridoma supernatants for their ability to bind to \u03b1IIb\u03b23 and inhibit CR. The immunoglobulin G1 (IgG1) mAb R6H8 completely inhibited CR at 20 \u03bcg\/mL. Paradoxically, at 5 \u03bcg\/mL, R6H8 initiated platelet aggregation and induced P-selectin expression, fibrinogen binding, and PAC-1 binding. At 20 \u03bcg\/mL, however, R6H8 completely inhibited aggregation induced by thrombin PAR-1 receptor activating peptide SFLLRN (T6; 25 \u03bcg\/mL) and T6-induced fibrinogen and PAC-1 binding to platelets. Platelet aggregation induced by R6H8 was inhibited by mAb IV.3, which blocks the Fc\u03b3IIa receptor (Fc\u03b3RIIa), and the Fab fragment of R6H8 did not induce platelet aggregation, suggesting that R6H8 binds to both \u03b1IIb\u03b23 and Fc\u03b3RIIa. Cryogenic electron microscopy analysis of the R6H8 Fab\u2013\u03b1IIb\u03b23 complex revealed that R6H8 (1) binds to the \u03b1IIb\u03b23 RGD binding pocket via an Arg-Tyr-Asp (RYD) sequence in its heavy chain complementarity-determining region 3; (2) interacts with \u03b23 Asp126, producing a reorientation of Asp126 and loss of the adjacent to metal ion-dependent adhesion site Ca2+; and (3) initiates swing-out of the \u03b23 hybrid domain. We conclude that R6H8 is an \u03b1IIb\u03b23 ligand-mimetic mAb that activates platelets via Fc\u03b3RIIa at low concentrations and potently inhibits platelet aggregation and CR at high concentrations. R6H8 simulates the actions of a number of pathological antibodies, including platelet-activating antibodies developed after therapy with \u03b1IIb\u03b23 inhibitors and platelet-activating antibodies in heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia. As such, it may be a valuable reagent for better understanding these disorders and identifying potential therapies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015368","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:02:13Z","timestamp":1742317333000},"page":"3518-3529","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["An \u03b1IIb\u03b23 ligand-mimetic murine monoclonal antibody that produces platelet activation by engaging the Fc\u03b3IIa receptor"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3552-881X","authenticated-orcid":false,"given":"Jialing","family":"Wang","sequence":"first","affiliation":[{"name":"1Laboratory of Molecular Electron Microscopy, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0116-6443","authenticated-orcid":false,"given":"Lorena","family":"Buitrago","sequence":"additional","affiliation":[{"name":"2Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"2Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Li","sequence":"additional","affiliation":[{"name":"2Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walz","sequence":"additional","affiliation":[{"name":"1Laboratory of Molecular Electron Microscopy, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-7155","authenticated-orcid":false,"given":"Barry S.","family":"Coller","sequence":"additional","affiliation":[{"name":"2Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"20","key":"2025072114014305700_bib1","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/bloodadvances.2021005142","article-title":"Platelet binding to polymerizing fibrin is avidity driven and requires activated \u03b1IIb\u03b23 but not fibrin cross-linking","volume":"5","author":"Buitrago","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"2025072114014305700_bib2","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood-2008-06-077891","article-title":"The GPIIb\/IIIa (integrin \u03b1IIb\u03b23) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend","volume":"112","author":"Coller","year":"2008","journal-title":"Blood"},{"issue":"7013","key":"2025072114014305700_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature02976","article-title":"Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics","volume":"432","author":"Xiao","year":"2004","journal-title":"Nature"},{"issue":"3","key":"2025072114014305700_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/ATVBAHA.119.313671","article-title":"Cryo-electron microscopy structure of the \u03b1IIb\u03b23-abciximab complex","volume":"40","author":"Ne\u0161i\u0107","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2025072114014305700_bib5","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1083\/jcb.99.6.2056","article-title":"Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb","volume":"99","author":"Shadle","year":"1984","journal-title":"J Cell Biol"},{"issue":"20","key":"2025072114014305700_bib6","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1074\/jbc.270.20.11947","article-title":"Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin \u03b23 subunit","volume":"270","author":"Honda","year":"1995","journal-title":"J Biol Chem"},{"issue":"13","key":"2025072114014305700_bib7","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/bloodadvances.2020001545","article-title":"Dominant role of \u03b1IIb\u03b23 in platelet interactions with cross-linked fibrin fragment D-dimer","volume":"4","author":"Buitrago","year":"2020","journal-title":"Blood Adv"},{"issue":"16","key":"2025072114014305700_bib8","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1182\/bloodadvances.2024013177","article-title":"An \u03b1IIb\u03b23 monoclonal antibody traps a semi-extended conformation and allosterically inhibits large ligand binding","volume":"8","author":"Wang","year":"2024","journal-title":"Blood Adv"},{"issue":"7","key":"2025072114014305700_bib9","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/bloodadvances.2020004166","article-title":"Electron microscopy shows that binding of monoclonal antibody PT25-2 primes integrin \u03b1IIb\u03b23 for ligand binding","volume":"5","author":"Ne\u0161i\u0107","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2025072114014305700_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat Methods"},{"issue":"4","key":"2025072114014305700_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"2025072114014305700_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"issue":"9","key":"2025072114014305700_bib13","first-page":"6703","article-title":"Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation","volume":"276","author":"Osdoit","year":"2001","journal-title":"J Biolchem"},{"issue":"20","key":"2025072114014305700_bib14","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1074\/jbc.270.20.11947","article-title":"Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin \u03b23 subunit","volume":"270","author":"Honda","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"2025072114014305700_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/toxins12010011","article-title":"A novel \u03b1(IIb)\u03b2(3) antagonist from snake venom prevents thrombosis without causing bleeding","volume":"12","author":"Kuo","year":"2019","journal-title":"Toxins"},{"issue":"4","key":"2025072114014305700_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.200801146","article-title":"Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3","volume":"182","author":"Springer","year":"2008","journal-title":"J Cell Biol"},{"issue":"20","key":"2025072114014305700_bib17","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","article-title":"Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation","volume":"260","author":"Shattil","year":"1985","journal-title":"J Biol Chem"},{"issue":"1","key":"2025072114014305700_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V70.1.307.307","article-title":"Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry","volume":"70","author":"Shattil","year":"1987","journal-title":"Blood"},{"issue":"1","key":"2025072114014305700_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9258(17)31252-8","article-title":"A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen","volume":"264","author":"Taub","year":"1989","journal-title":"J Biol Chem"},{"issue":"2","key":"2025072114014305700_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood.V70.2.475.475","article-title":"Increased surface expression of the membrane glycoprotein IIb\/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation","volume":"70","author":"Niiya","year":"1987","journal-title":"Blood"},{"issue":"9","key":"2025072114014305700_bib21","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood.V79.9.2303.bloodjournal7992303","article-title":"The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules","volume":"79","author":"Tomiyama","year":"1992","journal-title":"Blood"},{"issue":"25","key":"2025072114014305700_bib22","doi-asserted-by":"crossref","first-page":"18085","DOI":"10.1016\/S0021-9258(19)37156-X","article-title":"A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3","volume":"267","author":"Tomiyama","year":"1992","journal-title":"J Biol Chem"},{"issue":"5","key":"2025072114014305700_bib23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1074\/jbc.270.5.2268","article-title":"Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site","volume":"270","author":"Kodandapani","year":"1995","journal-title":"J Biol Chem"},{"issue":"8","key":"2025072114014305700_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/protein\/8.8.823","article-title":"Common molecular scaffold for two unrelated RGD molecules","volume":"8","author":"Ely","year":"1995","journal-title":"Protein Eng"},{"issue":"5","key":"2025072114014305700_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0049-3848(89)90391-5","article-title":"Calcium rise in human platelets elicited by anti-CD9 and -CD41 murine monoclonal antibodies","volume":"55","author":"Favier","year":"1989","journal-title":"Thromb Res"},{"issue":"5","key":"2025072114014305700_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V75.5.1087.1087","article-title":"Induction of platelet Ca2+ influx and mobilization by a monoclonal antibody to CD9 antigen","volume":"75","author":"Hato","year":"1990","journal-title":"Blood"},{"issue":"2-3","key":"2025072114014305700_bib27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s0167-4889(99)00105-6","article-title":"FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies","volume":"1451","author":"Qi","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2025072114014305700_bib28","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood.V81.7.1792.1792","article-title":"Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent","volume":"81","author":"De Reys","year":"1993","journal-title":"Blood"},{"issue":"4","key":"2025072114014305700_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-0037-1615653","article-title":"Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor","volume":"85","author":"Cauwenberghs","year":"2001","journal-title":"Thromb Haemost"},{"issue":"4","key":"2025072114014305700_bib30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood.V78.4.1019.1019","article-title":"Investigation of the mechanisms of monoclonal antibody-induced platelet activation","volume":"78","author":"Horsewood","year":"1991","journal-title":"Blood"},{"issue":"4","key":"2025072114014305700_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09537109209013181","article-title":"Heterogeneity of platelet Fc-receptor-dependent response to activating monoclonal antibodies","volume":"3","author":"Mazurov","year":"1992","journal-title":"Platelets"},{"issue":"9","key":"2025072114014305700_bib32","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V80.9.2261.2261","article-title":"Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression","volume":"80","author":"Tomiyama","year":"1992","journal-title":"Blood"},{"issue":"1","key":"2025072114014305700_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1432-1033.1990.tb15562.x","article-title":"Activation of platelets induced by mAb P256 specific for glycoprotein IIb-IIIa. Possible evidence for a role for IIb-IIIa in membrane signal transduction","volume":"190","author":"Bachelot","year":"1990","journal-title":"Eur J Biochem"},{"issue":"6","key":"2025072114014305700_bib34","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1055\/s-0038-1649982","article-title":"Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies","volume":"74","author":"Bachelot","year":"1995","journal-title":"Thromb Haemost"},{"issue":"1","key":"2025072114014305700_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.1991.tb04386.x","article-title":"Interaction of two GPIIb\/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII)","volume":"78","author":"Rubinstein","year":"1991","journal-title":"Br J Haematol"},{"key":"2025072114014305700_bib36","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"issue":"11","key":"2025072114014305700_bib37","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/jth.13803","article-title":"An \u03b1(II)(b) \u03b2(3) antagonist prevents thrombosis without causing Fc receptor \u03b3-chain IIa-mediated thrombocytopenia","volume":"15","author":"Kuo","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2025072114014305700_bib38","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood-2008-02-142125","article-title":"Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets","volume":"112","author":"Boylan","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2025072114014305700_bib39","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood-2012-07-443325","article-title":"Cooperative integrin\/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo","volume":"121","author":"Zhi","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2025072114014305700_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/09537109309013216","article-title":"Topographical association of the platelet Fc-receptor with the glycoprotein IIb-IIIa complex","volume":"4","author":"Berndt","year":"1993","journal-title":"Platelets"},{"key":"2025072114014305700_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2020.08.015","article-title":"Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: antibody deglycosylation only eliminates IgG2b binding","volume":"127","author":"Temming","year":"2020","journal-title":"Mol Immunol"},{"issue":"1","key":"2025072114014305700_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"26","key":"2025072114014305700_bib43","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Sch\u00f6nborn","year":"2023","journal-title":"Blood"},{"issue":"5","key":"2025072114014305700_bib44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"issue":"24","key":"2025072114014305700_bib45","doi-asserted-by":"crossref","first-page":"e031855","DOI":"10.1161\/JAHA.123.031855","article-title":"Critical analysis of thrombocytopenia associated with glycoprotein IIb\/IIIa inhibitors and potential role of zalunfiban, a novel small molecule glycoprotein inhibitor, in understanding the mechanism(s)","volume":"12","author":"Rikken","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2025072114014305700_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025072114014305700_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"issue":"3","key":"2025072114014305700_bib48","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI36745","article-title":"Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain","volume":"119","author":"Gao","year":"2009","journal-title":"J Clin Invest"},{"issue":"5","key":"2025072114014305700_bib49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jth.15265","article-title":"Platelet Fc\u03b3RIIA in immunity and thrombosis: adaptive immunothrombosis","volume":"19","author":"Patel","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"22","key":"2025072114014305700_bib50","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2025072114014305700_bib51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMc2406453","article-title":"Myeloma therapy for monoclonal gammopathy of thrombotic significance","volume":"391","author":"Salmasi","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"2025072114014305700_bib52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1182\/blood.2023020872","article-title":"PF4 activates the c-Mpl-Jak2 pathway in platelets","volume":"143","author":"Buka","year":"2024","journal-title":"Blood"},{"issue":"6680","key":"2025072114014305700_bib53","doi-asserted-by":"crossref","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"issue":"2","key":"2025072114014305700_bib54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"issue":"3","key":"2025072114014305700_bib55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.TP.0000110291.29370.C0","article-title":"Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates","volume":"77","author":"Koyama","year":"2004","journal-title":"Transplantation"},{"issue":"3","key":"2025072114014305700_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2025072114014305700_bib57","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1160\/TH04-12-0774","article-title":"The role of CD40 in CD40L-and antibody-mediated platelet activation","volume":"93","author":"Langer","year":"2005","journal-title":"Thromb Haemost"},{"issue":"3","key":"2025072114014305700_bib58","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4049\/jimmunol.0903888","article-title":"Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice","volume":"185","author":"Robles-Carrillo","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"2025072114014305700_bib59","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2004.03.023","article-title":"Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?","volume":"43","author":"Aukrust","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"489","key":"2025072114014305700_bib60","doi-asserted-by":"crossref","first-page":"eaar6584","DOI":"10.1126\/scitranslmed.aar6584","article-title":"A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity","volume":"11","author":"Karnell","year":"2019","journal-title":"Sci Transl Med"},{"issue":"7","key":"2025072114014305700_bib61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2309439","article-title":"Inhibition of CD40L with frexalimab in multiple sclerosis","volume":"390","author":"Vermersch","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"2025072114014305700_bib62","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0961203315574558","article-title":"First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus","volume":"24","author":"Tocoian","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"2025072114014305700_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-015-0757-4","article-title":"CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study","volume":"17","author":"Shock","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2025072114014305700_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1538-7836.2008.03212.x","article-title":"Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice","volume":"7","author":"Meyer","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025072114014305700_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.2024024442","article-title":"Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms","volume":"144","author":"Taylor","year":"2024","journal-title":"Blood"},{"issue":"7","key":"2025072114014305700_bib66","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/1078-0432.Ccr-16-0939","article-title":"Liver microvascular injury and thrombocytopenia of antibody-calicheamicin conjugates in cynomolgus monkeys-mechanism and monitoring","volume":"23","author":"Guffroy","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2025072114014305700_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-9560-5-7","article-title":"Increased platelet expression of FcGammaRIIa and its potential impact on platelet reactivity in patients with end stage renal disease","volume":"5","author":"Serrano","year":"2007","journal-title":"Thromb J"},{"issue":"2","key":"2025072114014305700_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacc.2018.04.046","article-title":"Fc\u03b3RIIa: a new cardiovascular risk marker","volume":"72","author":"Schneider","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2025072114014305700_bib69","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jacc.2024.08.051","article-title":"Platelet Fc\u03b3RIIa as a marker of cardiovascular risk after myocardial infarction","volume":"84","author":"Schneider","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"125","key":"2025072114014305700_bib70","doi-asserted-by":"crossref","first-page":"125ra32","DOI":"10.1126\/scitranslmed.3003576","article-title":"Structure-guided design of a high-affinity platelet integrin \u03b1IIb\u03b23 receptor antagonist that disrupts Mg2+ binding to the MIDAS","volume":"4","author":"Zhu","year":"2012","journal-title":"Sci Transl Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3518\/2402355\/blooda_adv-2024-015368-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3518\/2402355\/blooda_adv-2024-015368-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T18:01:53Z","timestamp":1753120913000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/14\/3518\/536220\/An-IIb-3-ligand-mimetic-murine-monoclonal-antibody"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":70,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015368","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,22]]},"published":{"date-parts":[[2025,7,10]]}}}